Bibliographic Details
| Title: |
Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study |
| Authors: |
García Del Muro, Xavier, Páez López-Bravo, David, Cuéllar-Rivas, Miler Andrés, Maroto, Pablo, Giannatempo, Patrizia, Castellano, Daniel, Climent, Miguel A., P. Valderrama, Begoña, Gómez de Liaño, Alfonso, López-Montero, Laura, Mina, Leonardo, Alcalá-López, Daniel, Sampayo-Cordero, Miguel, Necchi, Andrea |
| Source: |
European Urology Oncology; 20240101, Issue: Preprints |
| Abstract: |
The phase 2 ORPHEUS trial is one of the first prospective studies evaluating the efficacy and safety of retifanlimab (an anti-PD-1 agent) in patients with metastatic penile squamous cell carcinoma. Retifanlimab exhibited signals of clinical activity, with a manageable safety profile. |
| Database: |
Supplemental Index |
